How could a non-opioid painkiller improve the lives of people with chronic pain? What makes a non-opioid painkiller safer ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

There are many different medications to help with pain. Drugs in the non-opioid group are non-habit-forming and can address pain in various areas of the body. Non-opioid pain medications provide ...

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused ...

On 30 January 2025, the US Food and Drug Administration (FDA) approved the non-opioid medication suzetrigine (JOURNAVX), which was developed by Vertex Pharmaceuticals for moderate to severe acute ...

When discussing pain management with patients, Dr. Tuck emphasizes that EXPAREL is a non-opioid, long-acting local anesthetic designed to provide targeted pain relief. "In today’s environment ...

MIRA's Ketamir-2 shows promise in treating diabetic neuropathy, with a Phase 2a trial expected by late 2025 and human data in ...